Lung Neoplasms: all 7,334 studies
Page 40 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line ChemotherapyTerminatedNCT04352413Phase 2
- Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With ImmunomodulatorCompletedNCT04352335
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnNCT04348643Phase 1/2
- Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung CancerStatus unknownNCT04346914Phase 1
- Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLCCompletedNCT04345146Phase 2
- The Canada Lymph Node Score Project: A Crossover TrialCompletedNCT04342377Phase 3
- Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 BlockadeActive, not recruitingNCT04340882Phase 2
- An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain MetastasesStatus unknownNCT04339829Phase 2
- Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsActive, not recruitingNCT04336241Phase 1
- Pneumonitis After Radiotherapy for Lung CancerCompletedNCT04335409Not applicable
- Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLCStatus unknownNCT04331626Phase 4
- Evolution of Multiple Primary Lung Cancer (Evolution)Status unknownNCT04326751
- Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung CancerActive, not recruitingNCT04326153Phase 2
- A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone MetastasisStatus unknownNCT04325776Phase 2
- A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT04325763Phase 3
- Validation of Multiparametric Models and Circulating and Imaging Biomarkers to Improve Lung Cancer EARLY Detection.Status unknownNCT04323579
- SHOX2_PTGER4 DNA Methlyation in Lung CancerCompletedNCT04321499
- Behavioral Relaxation Approaches for Insomnia in Lung Cancer PatientsWithdrawnNCT04318249Not applicable
- Crizotinib in ALK Rearranged Non-small-cell Lung CancerStatus unknownNCT04317651
- Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled With Primary PreventionStatus unknownNCT04315766
- Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early DetectionStatus unknownNCT04315753
- Intraoperative Imaging of Pulmonary Nodules by SGM-101CompletedNCT04315467Phase 1
- Breaking Potentially Bad News in Lung Cancer Workup: Telephone Versus In-person Breaking of Final DiagnosisCompletedNCT04315207Not applicable
- National Cancer Institute "Cancer Moonshot Biobank"Active, not recruitingNCT04314401
- Radiogenomics in Aerodigestive Tract CancersCompletedNCT04314349
- Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm StudyStatus unknownNCT04314297Phase 2
- Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)CompletedNCT04314089Phase 1
- A Study of Smoking Cessation Patterns in Participants Undergoing Lung SurgeryCompletedNCT04313361
- A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT04311034Phase 1/2
- Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer RadiotherapyActive, not recruitingNCT04310891
- Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer PatientsActive, not recruitingNCT04310020Phase 2
- Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive, not recruitingNCT04310007Phase 2
- Modified Versus Traditional Thoracic Drainage After Thoracoscopic SurgeryStatus unknownNCT04309955Not applicable
- A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung CancerStatus unknownNCT04306926Phase 2
- Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation TherapyActive, not recruitingNCT04305613
- Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLCStatus unknownNCT04304638
- Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung CancerActive, not recruitingNCT04304248Phase 2
- Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLCStatus unknownNCT04303130Phase 2
- Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant MesotheliomaActive, not recruitingNCT04300244Phase 2
- A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or RecurrenceCompletedNCT04298606Early Phase 1
- Lorlatinib Combinations in Lung CancerStatus unknownNCT04292119Phase 1/2
- A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USAApproved for marketingNCT04291937
- HMPL-453 in Advanced Malignant MesotheliomaStatus unknownNCT04290325Phase 2
- Tumor Mutational Burden in Lung Cancer PatientsTerminatedNCT04289259
- Detection of Lung Cancer by Plasma LipidsCompletedNCT04287712
- Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.CompletedNCT04285866
- Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung CancerActive, not recruitingNCT04285671Phase 1/2
- Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung CancerStatus unknownNCT04275687Phase 2
- A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) ExpressionTerminatedNCT04274907Phase 1
- A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 TabletsStatus unknownNCT04273815Phase 1/2
- Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung CancerCompletedNCT04271384Phase 2
- Investigation of an Abdominal Compression DeviceStatus unknownNCT04270890Not applicable
- Lung Nodule Imaging Biobank for Radiomics and AI ResearchStatus unknownNCT04270799
- Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)Active, not recruitingNCT04268550Phase 2
- Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)WithdrawnNCT04267913Phase 2
- A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung CancerWithdrawnNCT04267237Phase 2
- Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With PembrolizumabSuspendedNCT04266730Phase 1
- Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung CancerCompletedNCT04266691
- Cancer Genome Atlas of China:Lung CancerStatus unknownNCT04266483
- KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLCTerminatedNCT04265534Phase 2
- Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability StudyCompletedNCT04264325
- Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural EffusionStatus unknownNCT04263688
- High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)Active, not recruitingNCT04263467Not applicable
- Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung CancerCompletedNCT04263051Phase 2
- Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT04262869Phase 2
- Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung CancerCompletedNCT04262856Phase 2
- A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWithdrawnNCT04262388Phase 2
- Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung CancerStatus unknownNCT04260295
- Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung CancerCompletedNCT04257864
- A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung CancerCompletedNCT04254497
- This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in PatientsStatus unknownNCT04254471Phase 2/3
- Liquid Biopsy Using Methylation Sequencing for Lung CancerCompletedNCT04253509
- Patient Skin Dose in Interventional RadiologyCompletedNCT04246125
- Classification of Benign and Malignant Lung Nodules Based on CT Raw DataCompletedNCT04241614
- Initiative in LYon for Lung cAncer Screening Development - Prevalence StudyCompletedNCT04240418
- A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerStatus unknownNCT04239833Phase 3
- Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following ResectionCompletedNCT04238130
- A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)Status unknownNCT04234607Phase 3
- 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung CancerCompletedNCT04233476Phase 3
- Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR MutationCompletedNCT04233021Phase 2
- Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung CancersCompletedNCT04230408Phase 2
- Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin AmericaCompletedNCT04227457
- Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLCActive, not recruitingNCT04227028Phase 1
- Clinical Utility of Liquid Biopsy in Brigatinib ALK+ PatientsActive, not recruitingNCT04223596Phase 2
- Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer PatientsCompletedNCT04222335Not applicable
- A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.Status unknownNCT04220268
- Early Cancer Detection Test - Lung Cancer ChinaStatus unknownNCT04216511
- Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04213937Phase 2
- Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
- Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT04213170Phase 2
- Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerCompletedNCT04212052Phase 2
- Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With CrizotinibTerminatedNCT04211922Phase 2
- Anlotinib Combined With Nivolumab for Non-Small Cell Lung CancerStatus unknownNCT04211896Phase 2
- Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLCStatus unknownNCT04211090Phase 2
- Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary NodulesCompletedNCT04211051Not applicable
- Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung CancerTerminatedNCT04210037Phase 1/2
- Analysis of Screen-detected Lung Cancers' Genomic TraitsActive, not recruitingNCT04204499
- INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)WithdrawnNCT04203511Phase 3
- Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04203485Phase 3
- Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer PatientsStatus unknownNCT04203095